{"id":5441,"date":"2025-07-20T10:00:00","date_gmt":"2025-07-20T17:00:00","guid":{"rendered":"http:\/\/54.162.83.219\/?p=5441"},"modified":"2025-07-17T18:21:35","modified_gmt":"2025-07-18T01:21:35","slug":"laneige-sleeping-mask-japan-launch-2025-2","status":"publish","type":"post","link":"https:\/\/guru.today\/?p=5441","title":{"rendered":"Samsung Bioepis Signs Licensing Deal with U.S.-Based Harrow for Ophthalmology Biosimilars in North America"},"content":{"rendered":"\n<figure class=\"wp-block-image size-full is-resized\"><img fetchpriority=\"high\" decoding=\"async\" width=\"500\" height=\"333\" src=\"http:\/\/54.162.83.219\/wp-content\/uploads\/art_17527911833077_14d9ba.jpg\" alt=\"\" class=\"wp-image-5443\" style=\"width:740px;height:auto\" srcset=\"https:\/\/guru.today\/wp-content\/uploads\/art_17527911833077_14d9ba.jpg 500w, https:\/\/guru.today\/wp-content\/uploads\/art_17527911833077_14d9ba-300x200.jpg 300w\" sizes=\"(max-width: 500px) 100vw, 500px\" \/><figcaption class=\"wp-element-caption\">Photo=Samsung Biopics<\/figcaption><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Samsung Bioepis has signed a licensing agreement with U.S.-based ophthalmic pharmaceutical company Harrow for the commercialization rights of its biosimilar treatments for eye diseases in North America. Under the agreement, Harrow will be responsible for the sales and marketing of two ophthalmology biosimilars currently being developed by Samsung Bioepis. This marks a new partnership following the termination of its previous agreement with Biogen.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">On July 17 (local time), Harrow announced that it had entered into a License, Development, and Commercialization Agreement (DCA) with Samsung Bioepis for the North American rights to two biosimilars: BYOOVIZ and OPUVIZ. Specific details of the agreement, including its duration and financial terms, were not disclosed.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Harrow will assume full commercial responsibility for both products once commercialization rights are fully transferred from Biogen to Samsung Bioepis by the end of this year. The deal is expected to boost Samsung Bioepis\u2019s market share and revenue in the U.S. biosimilar sector.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">BYOOVIZ, approved by the U.S. Food and Drug Administration (FDA) in September 2021, is the first ophthalmology biosimilar approved in the United States. It has been commercially available since June 2022 and is used to treat neovascular (wet) age-related macular degeneration (AMD), macular edema following retinal vein occlusion (RVO), and myopic choroidal neovascularization (mCNV).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">OPUVIZ was approved by the FDA in May 2024. It is indicated for the treatment of wet AMD, macular edema following RVO, diabetic macular edema (DME), and diabetic retinopathy (DR).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The new partnership follows the expiration of Samsung Bioepis\u2019s previous licensing agreement with Biogen. In October 2023, Biogen notified Samsung Bioepis of the termination of their 2019 development and commercialization agreement covering the U.S. and Canadian markets. Since then, Samsung Bioepis has focused on ensuring a smooth transfer of commercialization rights.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This new alliance is expected to serve as a major stepping stone for the expanded supply of Samsung Bioepis\u2019s ophthalmology biosimilars in the U.S. market. By leveraging Harrow\u2019s strong local sales and distribution network, Samsung Bioepis aims to reduce the burden of direct commercialization while enhancing market penetration.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cWe are pleased to partner with Harrow, a leading ophthalmic pharmaceutical company with proven commercial strength in the North American market,\u201d said a Samsung Bioepis Business Development representative. \u201cThrough close collaboration with both Biogen and Harrow, we will ensure a seamless transition and continued service to customers and patients in the U.S.\u201d<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Samsung Bioepis has signed a licensing agreement with U.S.-based ophthalmic pharmaceutical company Harrow for the commercialization rights of<\/p>\n","protected":false},"author":6,"featured_media":5443,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_eb_attr":"","footnotes":""},"categories":[38,28,54],"tags":[],"class_list":["post-5441","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-all-stories","category-biz-beyond","category-top-section"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.0 (Yoast SEO v28.0) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Laneige Launches Renewed Sleeping Masks in Japan After Selling 58.3 Million Globally<\/title>\n<meta name=\"description\" content=\"Laneige is launching renewed versions of its bestselling Sleeping Mask in Japan on August 30. Enhanced with sleep science technology, the products target Japan\u2019s booming home skincare market.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/guru.today\/?p=5441\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Samsung Bioepis Signs Licensing Deal with U.S.-Based Harrow for Ophthalmology Biosimilars in North America\" \/>\n<meta property=\"og:description\" content=\"Laneige is launching renewed versions of its bestselling Sleeping Mask in Japan on August 30. Enhanced with sleep science technology, the products target Japan\u2019s booming home skincare market.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/guru.today\/?p=5441\" \/>\n<meta property=\"og:site_name\" content=\"GURU TODAY\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-20T17:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/guru.today\/wp-content\/uploads\/art_17527911833077_14d9ba.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"500\" \/>\n\t<meta property=\"og:image:height\" content=\"333\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"WooJae Adams\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"WooJae Adams\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/guru.today\\\/?p=5441#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/guru.today\\\/?p=5441\"},\"author\":{\"name\":\"WooJae Adams\",\"@id\":\"https:\\\/\\\/guru.today\\\/#\\\/schema\\\/person\\\/2828282da168fd40c6c71cc5c58063b4\"},\"headline\":\"Samsung Bioepis Signs Licensing Deal with U.S.-Based Harrow for Ophthalmology Biosimilars in North America\",\"datePublished\":\"2025-07-20T17:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/guru.today\\\/?p=5441\"},\"wordCount\":412,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/guru.today\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/guru.today\\\/?p=5441#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/guru.today\\\/wp-content\\\/uploads\\\/art_17527911833077_14d9ba.jpg\",\"articleSection\":[\"All Stories\",\"Biz &amp; Beyond\",\"Top section\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/guru.today\\\/?p=5441#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/guru.today\\\/?p=5441\",\"url\":\"https:\\\/\\\/guru.today\\\/?p=5441\",\"name\":\"Laneige Launches Renewed Sleeping Masks in Japan After Selling 58.3 Million Globally\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/guru.today\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/guru.today\\\/?p=5441#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/guru.today\\\/?p=5441#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/guru.today\\\/wp-content\\\/uploads\\\/art_17527911833077_14d9ba.jpg\",\"datePublished\":\"2025-07-20T17:00:00+00:00\",\"description\":\"Laneige is launching renewed versions of its bestselling Sleeping Mask in Japan on August 30. Enhanced with sleep science technology, the products target Japan\u2019s booming home skincare market.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/guru.today\\\/?p=5441#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/guru.today\\\/?p=5441\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/guru.today\\\/?p=5441#primaryimage\",\"url\":\"https:\\\/\\\/guru.today\\\/wp-content\\\/uploads\\\/art_17527911833077_14d9ba.jpg\",\"contentUrl\":\"https:\\\/\\\/guru.today\\\/wp-content\\\/uploads\\\/art_17527911833077_14d9ba.jpg\",\"width\":500,\"height\":333},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/guru.today\\\/?p=5441#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/guru.today\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Samsung Bioepis Signs Licensing Deal with U.S.-Based Harrow for Ophthalmology Biosimilars in North America\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/guru.today\\\/#website\",\"url\":\"https:\\\/\\\/guru.today\\\/\",\"name\":\"GURU TODAY\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/guru.today\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/guru.today\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/guru.today\\\/#organization\",\"name\":\"GURU TODAY\",\"url\":\"https:\\\/\\\/guru.today\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/guru.today\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"http:\\\/\\\/54.162.83.219\\\/wp-content\\\/uploads\\\/Logo_white-1.png\",\"contentUrl\":\"http:\\\/\\\/54.162.83.219\\\/wp-content\\\/uploads\\\/Logo_white-1.png\",\"width\":1000,\"height\":167,\"caption\":\"GURU TODAY\"},\"image\":{\"@id\":\"https:\\\/\\\/guru.today\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/guru.today\\\/#\\\/schema\\\/person\\\/2828282da168fd40c6c71cc5c58063b4\",\"name\":\"WooJae Adams\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e88c0f1716dfa0dbe86fe3130618c868c4702e8e101863d13a42f20ee8e1f9e1?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e88c0f1716dfa0dbe86fe3130618c868c4702e8e101863d13a42f20ee8e1f9e1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e88c0f1716dfa0dbe86fe3130618c868c4702e8e101863d13a42f20ee8e1f9e1?s=96&d=mm&r=g\",\"caption\":\"WooJae Adams\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Laneige Launches Renewed Sleeping Masks in Japan After Selling 58.3 Million Globally","description":"Laneige is launching renewed versions of its bestselling Sleeping Mask in Japan on August 30. Enhanced with sleep science technology, the products target Japan\u2019s booming home skincare market.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/guru.today\/?p=5441","og_locale":"en_US","og_type":"article","og_title":"Samsung Bioepis Signs Licensing Deal with U.S.-Based Harrow for Ophthalmology Biosimilars in North America","og_description":"Laneige is launching renewed versions of its bestselling Sleeping Mask in Japan on August 30. Enhanced with sleep science technology, the products target Japan\u2019s booming home skincare market.","og_url":"https:\/\/guru.today\/?p=5441","og_site_name":"GURU TODAY","article_published_time":"2025-07-20T17:00:00+00:00","og_image":[{"width":500,"height":333,"url":"https:\/\/guru.today\/wp-content\/uploads\/art_17527911833077_14d9ba.jpg","type":"image\/jpeg"}],"author":"WooJae Adams","twitter_card":"summary_large_image","twitter_misc":{"Written by":"WooJae Adams","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/guru.today\/?p=5441#article","isPartOf":{"@id":"https:\/\/guru.today\/?p=5441"},"author":{"name":"WooJae Adams","@id":"https:\/\/guru.today\/#\/schema\/person\/2828282da168fd40c6c71cc5c58063b4"},"headline":"Samsung Bioepis Signs Licensing Deal with U.S.-Based Harrow for Ophthalmology Biosimilars in North America","datePublished":"2025-07-20T17:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/guru.today\/?p=5441"},"wordCount":412,"commentCount":0,"publisher":{"@id":"https:\/\/guru.today\/#organization"},"image":{"@id":"https:\/\/guru.today\/?p=5441#primaryimage"},"thumbnailUrl":"https:\/\/guru.today\/wp-content\/uploads\/art_17527911833077_14d9ba.jpg","articleSection":["All Stories","Biz &amp; Beyond","Top section"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/guru.today\/?p=5441#respond"]}]},{"@type":"WebPage","@id":"https:\/\/guru.today\/?p=5441","url":"https:\/\/guru.today\/?p=5441","name":"Laneige Launches Renewed Sleeping Masks in Japan After Selling 58.3 Million Globally","isPartOf":{"@id":"https:\/\/guru.today\/#website"},"primaryImageOfPage":{"@id":"https:\/\/guru.today\/?p=5441#primaryimage"},"image":{"@id":"https:\/\/guru.today\/?p=5441#primaryimage"},"thumbnailUrl":"https:\/\/guru.today\/wp-content\/uploads\/art_17527911833077_14d9ba.jpg","datePublished":"2025-07-20T17:00:00+00:00","description":"Laneige is launching renewed versions of its bestselling Sleeping Mask in Japan on August 30. Enhanced with sleep science technology, the products target Japan\u2019s booming home skincare market.","breadcrumb":{"@id":"https:\/\/guru.today\/?p=5441#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/guru.today\/?p=5441"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/guru.today\/?p=5441#primaryimage","url":"https:\/\/guru.today\/wp-content\/uploads\/art_17527911833077_14d9ba.jpg","contentUrl":"https:\/\/guru.today\/wp-content\/uploads\/art_17527911833077_14d9ba.jpg","width":500,"height":333},{"@type":"BreadcrumbList","@id":"https:\/\/guru.today\/?p=5441#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/guru.today\/"},{"@type":"ListItem","position":2,"name":"Samsung Bioepis Signs Licensing Deal with U.S.-Based Harrow for Ophthalmology Biosimilars in North America"}]},{"@type":"WebSite","@id":"https:\/\/guru.today\/#website","url":"https:\/\/guru.today\/","name":"GURU TODAY","description":"","publisher":{"@id":"https:\/\/guru.today\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/guru.today\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/guru.today\/#organization","name":"GURU TODAY","url":"https:\/\/guru.today\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/guru.today\/#\/schema\/logo\/image\/","url":"http:\/\/54.162.83.219\/wp-content\/uploads\/Logo_white-1.png","contentUrl":"http:\/\/54.162.83.219\/wp-content\/uploads\/Logo_white-1.png","width":1000,"height":167,"caption":"GURU TODAY"},"image":{"@id":"https:\/\/guru.today\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/guru.today\/#\/schema\/person\/2828282da168fd40c6c71cc5c58063b4","name":"WooJae Adams","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e88c0f1716dfa0dbe86fe3130618c868c4702e8e101863d13a42f20ee8e1f9e1?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e88c0f1716dfa0dbe86fe3130618c868c4702e8e101863d13a42f20ee8e1f9e1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e88c0f1716dfa0dbe86fe3130618c868c4702e8e101863d13a42f20ee8e1f9e1?s=96&d=mm&r=g","caption":"WooJae Adams"}}]}},"rttpg_featured_image_url":{"full":["https:\/\/guru.today\/wp-content\/uploads\/art_17527911833077_14d9ba.jpg",500,333,false],"landscape":["https:\/\/guru.today\/wp-content\/uploads\/art_17527911833077_14d9ba.jpg",500,333,false],"portraits":["https:\/\/guru.today\/wp-content\/uploads\/art_17527911833077_14d9ba.jpg",500,333,false],"thumbnail":["https:\/\/guru.today\/wp-content\/uploads\/art_17527911833077_14d9ba-150x150.jpg",150,150,true],"medium":["https:\/\/guru.today\/wp-content\/uploads\/art_17527911833077_14d9ba-300x200.jpg",300,200,true],"large":["https:\/\/guru.today\/wp-content\/uploads\/art_17527911833077_14d9ba.jpg",500,333,false],"1536x1536":["https:\/\/guru.today\/wp-content\/uploads\/art_17527911833077_14d9ba.jpg",500,333,false],"2048x2048":["https:\/\/guru.today\/wp-content\/uploads\/art_17527911833077_14d9ba.jpg",500,333,false],"morenews-large":["https:\/\/guru.today\/wp-content\/uploads\/art_17527911833077_14d9ba.jpg",500,333,false],"morenews-medium":["https:\/\/guru.today\/wp-content\/uploads\/art_17527911833077_14d9ba.jpg",500,333,false]},"rttpg_author":{"display_name":"WooJae Adams","author_link":"https:\/\/guru.today\/?author=6"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/guru.today\/?cat=38\" rel=\"category\">All Stories<\/a> <a href=\"https:\/\/guru.today\/?cat=28\" rel=\"category\">Biz &amp; Beyond<\/a> <a href=\"https:\/\/guru.today\/?cat=54\" rel=\"category\">Top section<\/a>","rttpg_excerpt":"Samsung Bioepis has signed a licensing agreement with U.S.-based ophthalmic pharmaceutical company Harrow for the commercialization rights of","_links":{"self":[{"href":"https:\/\/guru.today\/index.php?rest_route=\/wp\/v2\/posts\/5441","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/guru.today\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/guru.today\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/guru.today\/index.php?rest_route=\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/guru.today\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=5441"}],"version-history":[{"count":1,"href":"https:\/\/guru.today\/index.php?rest_route=\/wp\/v2\/posts\/5441\/revisions"}],"predecessor-version":[{"id":5444,"href":"https:\/\/guru.today\/index.php?rest_route=\/wp\/v2\/posts\/5441\/revisions\/5444"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/guru.today\/index.php?rest_route=\/wp\/v2\/media\/5443"}],"wp:attachment":[{"href":"https:\/\/guru.today\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=5441"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/guru.today\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=5441"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/guru.today\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=5441"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}